Accéder au contenu
MilliporeSigma

Alterations of functional circuitry in aging brain and the impact of mutated APP expression.

Neurobiology of aging (2018-07-29)
Elaine L Bearer, Brett C Manifold-Wheeler, Christopher S Medina, Aaron G Gonzales, Frances L Chaves, Russell E Jacobs
RÉSUMÉ

Alzheimer's disease (AD) is a disease of aging that results in cognitive impairment, dementia, and death. Pathognomonic features of AD are amyloid plaques composed of proteolytic fragments of the amyloid precursor protein (APP) and neurofibrillary tangles composed of hyperphosphorylated tau protein. One type of familial AD occurs when mutant forms of APP are inherited. Both APP and tau are components of the microtubule-based axonal transport system, which prompts the hypothesis that axonal transport is disrupted in AD, and that such disruption impacts cognitive function. Transgenic mice expressing mutated forms of APP provide preclinical experimental systems to study AD. Here, we perform manganese-enhanced magnetic resonance imaging to study transport from hippocampus to forebrain in four cohorts of living mice: young and old wild-type and transgenic mice expressing a mutant APP with both Swedish and Indiana mutations (APPSwInd). We find that transport is decreased in normal aging and further altered in aged APPSwInd plaque-bearing mice. These findings support the hypothesis that transport deficits are a component of AD pathology and thus may contribute to cognitive deficits.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-APP A4, a. a. 66 à 81 de l′APP {NT}, clone 22C11, clone 22C11, Chemicon®, from mouse
Sigma-Aldrich
Anticorps de chèvre anti-IgG de lapin (chaînes H + L) conjugué à la HRP, 1 mg/mL, Chemicon®
Sigma-Aldrich
Anti-amyloid beta peptide (MOAB-2), pan Antibody, clone 6C3, clone 6C3, from mouse
Sigma-Aldrich
Anticorps anti-superoxyde dismutase 1, serum, Chemicon®